Skip to main content

Table 3 Treatment outcome during 28 days follow up period

From: Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children

Treatment outcome

Treatment arm

p-value

Artefan®

(n = 84)

Coartem®

(n = 75)

Late clinical failure (LCF)

1 (3.6%)

1 (1.3%)

0.31

Late parasitological failure (LPF)

12 (15.4%)

17 (22.7%)

0.32

Adequate clinical and parasitological response (ACPR)

64 (82.1%)

56 (74.7%)

0.44